All In Biotech

Drug Trial Radar · NCT06525935

A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Once-Weekly CT-388 Administered for 48 Weeks to Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 469 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

469

Actual

Start

Aug 16, 2024

Primary completion

Dec 8, 2025

Study completion Dec 8, 2025

Sponsor

Lead sponsor
Carmot Therapeutics, Inc.Industry
Sponsor type
Industry
Collaborators
Hoffmann-La Roche
First posted
Jul 29, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, randomized, double-blind, placebo-controlled, parallel group dose-finding study to evaluate the efficacy and safety of enicepatide at low, middle, and high doses in participants with obesity or who are overweight with at least one weight-related comorbidity.

Conditions

  • Obesity
  • Overweight

Interventions

  • PlaceboDrug

    Placebo will be volume- matched and administered subcutaneously (SC) once weekly.

  • EnicepatideDrug

    Enicepatide will be administered subcutaneously (SC) once weekly at the randomized dosing regimen.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change in Body Weight from Baseline to Week 48Time frame: Baseline to Week 48

Locations

34 sites in 1 country. Site status is shown where the registry gives one.

  • Alabama Clinical Therapeutics, LLC

    Birmingham, Alabama

  • Central Alabama Research

    Homewood, Alabama

  • The Institute for Liver Health II LLC dba Arizona Clinical Trials; Arizona Liver Health

    Mesa, Arizona

  • Amicis Research Center - Anaheim

    Anaheim, California

  • Ark Clinical-Fountain Valley

    Fountain Valley, California

  • Ark Clinical Research - Long Beach

    Long Beach, California

  • Velocity Clinical Research - Los Angeles

    Los Angeles, California

  • Infinity Clinical Research

    Norco, California

  • Amicis Research Center

    Northridge, California

  • Prospective Research Innovations Inc.

    Rancho Cucamonga, California

  • Orange County Research Center

    Tustin, California

  • Amicis Research Center - West Hills

    West Hills, California

  • Tampa Bay Medical Research, Inc.

    Clearwater, Florida

  • Progressive Medical Research

    Port Orange, Florida

  • Louisville Metabolic and Atherosclerosis Research Center (L-MARC)

    Louisville, Kentucky

  • The Center for Pharmaceutical Research

    Kansas City, Missouri

  • Mercury Street Medical Group

    Butte, Montana

  • Neurobehavioral Research, Inc. (NBR)

    Cedarhurst, New York

  • Lucas Research, Inc

    Morehead City, North Carolina

  • Velocity Clinical Research - Cincinnati

    Cincinnati, Ohio

  • Velocity Clinical Research, Providence

    East Greenwich, Rhode Island

  • Tribe Clinical Research

    Greenville, South Carolina

  • Alliance for Multispecialty Research, LLC

    Knoxville, Tennessee

  • Clinical Research Associates, Inc.

    Nashville, Tennessee

  • Texas Diabetes & Endocrinology, P.A.

    Austin, Texas

  • Apex Mobile Clinical Research

    Bellaire, Texas

  • Velocity Clinical Research - Dallas

    Dallas, Texas

  • FutureSearch Trials of Dallas, LLC

    Dallas, Texas

  • University of Texas Southwestern

    Dallas, Texas

  • Pinnacle Clinical Research

    San Antonio, Texas

  • Elevate Clinical

    Seabrook, Texas

  • Impact Research Institute

    Waco, Texas

  • Chrysalis Clinical Research

    St. George, Utah

  • National Clinical Research - Richmond, Inc

    Richmond, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.